Telomir Pharmaceuticals Inc (TELO)

Jul 24, 2025

What analysts say about Telomir Pharmaceuticals Inc. stockSkyrocketing profit margins - PrintWeekIndia

Jul 24, 2025

Jul 24, 2025

When is the best time to buy Telomir Pharmaceuticals Inc. stockSuperior risk-adjusted returns - jammulinksnews.com

Jul 24, 2025

Jul 24, 2025

Telomir Pharmaceuticals Reports Telomir-1's Unique Profile Restores Mitochondrial Health While Improving Oxidative Stress Without Promoting Cell Proliferation in Diseased Human Cell Lines Highlighting Potential Relevance to Neurodegenerative Pathway - Reno Gazette Journal

Jul 24, 2025

Jul 24, 2025

Telomir Pharmaceuticals stock surges on promising Progeria treatment results - Investing.com

Jul 24, 2025

Jul 24, 2025

Telomir-1 shows promise in restoring mitochondrial function By Investing.com - Investing.com South Africa

Jul 24, 2025

Jul 24, 2025

Telomir-1 shows promise in restoring mitochondrial function - Investing.com Australia

Jul 24, 2025

Jul 24, 2025

Revolutionary Mitochondrial Drug Could Transform Treatment of Alzheimer's, Parkinson's, and ALS - Stock Titan

Jul 24, 2025

Jul 23, 2025

Telomir Pharmaceuticals Inc. Stock Analysis and ForecastExceptional trading results - Autocar Professional

Jul 23, 2025

Jul 23, 2025

Telomir Pharmaceuticals Inc (NASDAQ: TELO) Stock Sentiment: What’s Wall Street Saying? - Stocksregister

Jul 23, 2025

Jul 23, 2025

Telomir Pharmaceuticals Inc (TELO) Stock: A Year of Stock Market Dynamics - investchronicle.com

Jul 23, 2025

Jul 22, 2025

Is Telomir Pharmaceuticals Inc. a good long term investmentRecord-setting profit potential - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

What drives Telomir Pharmaceuticals Inc. stock priceDynamic profit opportunities - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

What makes Telomir Pharmaceuticals Inc. stock price move sharplyGrowth Stock Monitor - Newser

Jul 22, 2025

Jul 21, 2025

Pre-market Movers: PMN, GCTK, TELO, SRPT... - RTTNews

Jul 21, 2025

Jul 19, 2025

Why Is Telomir Pharmaceuticals Stock (TELO) Up 150% Today? - MSN

Jul 19, 2025

Jul 18, 2025

Healthcare Stocks Move in Pre-Market Session: Telomir Pharmaceuticals, Mesoblast, and More - AInvest

Jul 18, 2025

Jul 18, 2025

Telomir Demonstrates Telomir-1 Reverses Epigenetic Gene Silencing of STAT1, Restoring Tumor Suppressor in Human Prostate Cancer Cells, Outperforming Chemotherapy and Rapamycin - Lohud

Jul 18, 2025

Jul 18, 2025

Telomir Pharmaceuticals Stock Price, Quotes and Forecasts - Benzinga

Jul 18, 2025

Jul 18, 2025

Telomir skyrockets on preclinical data backing epigenetic potential of lead asset - FirstWord Pharma

Jul 18, 2025

Jul 18, 2025

Dow Falls Over 200 Points; 3M Earnings Top Views - Benzinga

Jul 18, 2025

Jul 18, 2025

Telomir Pharma Skyrockets Nearly 139% After-Hours As Cancer Drug Shows Breakthrough Results, Beats Chemo In Human Cell Tests - NewsBreak: Local News & Alerts

Jul 18, 2025

Jul 18, 2025

Telomir Pharmaceuticals Skyrockets 150% on Breakthrough Preclinical Cancer Results - MSN

Jul 18, 2025

Jul 18, 2025

Telomir Pharmaceuticals: A Disruptive Force in Prostate Cancer Therapy with Epigenetic Innovation - AInvest

Jul 18, 2025

Jul 18, 2025

Telomir Pharmaceuticals stock soars after promising cancer treatment data - Investing.com

Jul 18, 2025

Jul 18, 2025

Telomir Pharma Jumps In After-Hours Trading After Drug Reverses Damage In Progeria Cells; Retail Eyes Bigger Gains - Stocktwits

Jul 18, 2025

Jul 18, 2025

Telomir Pharmaceuticals stock soars after promising cancer treatment data By Investing.com - Investing.com UK

Jul 18, 2025

Jul 18, 2025

Cancer Breakthrough Sends Telomir Pharma Stock Exploding 157% - Wall Street Pit

Jul 18, 2025

Jul 18, 2025

Telomir-1 shows stronger epigenetic effects than standard drugs in cancer study - Investing.com Australia

Jul 18, 2025